Enzym

Enzym

ICO Ended
13,898 Views
Enzym is a dApp and the ZYM is an ERC20 token. We use the blockchain to bring transparency and security to the user.

Enzym is a free mobile game that triggers encounters outside our usual circles (friends, family, colleagues...). Players can receive challenges/missions that will lead to meetings. Every challenge is different. It can be played by two or more people, with strangers or with friends, over a few hours or several days…

To play, a user needs ZYMs, the fuel of the application. Some actions will make him win, other will make him lose ZYMs.
6.0
TOTAL SCORE
7.3
ICO PROFILE

(weight: 45%)

5
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 15 Oct 2018 - 29 Oct 2018
ICO Time: 19 Nov 2018 - 10 Dec 2018
Country: France
Token info
Ticker: ZYM
Platform: Ethereum
Token Type: ERC20
Available for sale: 65,000,000 ZYM (65%)
Financial
ICO Price: 1 ZYM = 0.000038 ETH
Accepting: BTC, ETH
Soft cap: 1,250 ETH
Hard cap: 25,000 ETH
S2 (2018)
ICO platform up and running.<br /> <br /> Enzym prototype​: proof-of-concept of some parts of future user interactions Pre-sale: October 22 - November 5, 2018.<br /> <br /> ICO: November 19 - December 10, 2018.<br />
Q1 (2019)
Recruitment.<br /> <br /> Start of the development of the Enzym dApp.<br /> <br /> Selection of a communication agency.<br /> <br /> Start of the marketing of tokens to European venue owners.<br />
Q2 (2019)
Enzym platform v1​: functional mobile app, data storage on servers.<br /> <br /> Determination of the European marketing strategy.<br /> <br /> Technical validation of the distribution of tokens via the newsletter and the QR code technology v1.<br />
Q3 (2019)
Launch of an operational Enzym platform in French and English.<br /> <br /> Start of promotional communication: media reports, content creation and diffusion, events in major cities in France and in the US.<br />
Q4 (2019)
Enzym platform v2​: operational blockchain, user interactions through smart contracts,<br /> <br /> end-to-end data encryption, decentralized user data.<br /> <br /> Constitution of a European team for the sale of tokens.<br /> <br /> Study and validation of technical solutions for the distribution of tokens in venues.<br />
S1 (2020)
Enzym platform v2​: increased decentralization, near-serverless operation Translations, UX modifications : Russian, Spanish, Portuguese.<br /> <br /> Promotion : Russia, Spain, Portugal, Latin America.<br />
S2 (2020)
Translations, UX modifications and promotion : Indian, Mandarin Chinese and Japanese.
Yannick Barnel
Co-founder - CEO
Participates in a number of projects
Sylvain Duchesne
Co-founder - CTO
Participates in a number of projects
Jeremy Coleman
Chief Marketing Officer
Participates in a number of projects
Alfred Gautier
Artistic director
Participates in a number of projects
Théophile Batoz
Software Engineer
No participating data
Sophea Sock
UI / UX designer
No participating data
Kevin Fuks
Community Manager
Participates in a number of projects
Octave Rolland
Writer
Participates in a number of projects
Pauline Rochette
Community Manager
Participates in a number of projects
Guillaume Larochette
Community Manager
No participating data

Advisors (4)

Eric Burgel
Président - B2Expand
No participating data
Manon Burgel
CEO - B2Expand
No participating data
Rémi Burgel
CTO - B2Expand
No participating data
Nicolas Paillet
Legal and financial advisor - Public accountant
No participating data
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
AITrading
AITrading is a revolutionary trading ecosystem, which simplifies experience both for experienced traders as well as for newcomers. It gives tens millions traders the ability to live normal life while AI works for them. AITrading combines AI and Blockchain technologies with trading community capabilities on a single platform.
Upcoming
Verifier
Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.
Upcoming
Universal Reward Protocol
By accepting to share their shopping data with the network, a shopper earns reward tokens, while the data is used by retailers to build redemption offers that best suit each customer’s needs. Shoppers can redeem their tokens through these exclusive and personalized offers.
Upcoming
Escrowblock
The aim of the project is to create an EscrowBlock platform for the Ethereum network blockchain. Such a platform can work as an independent environment, or be integrated into other Smart contracts, to provide escrow services as part of any other projects. The team will start the project on Mainnet Ethereum blockchain and then make a fork for providing an independent service.
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.